New Patch “Sticks It” To ADHD Data Presented At Major Medical Meeting Underscores U Efficacy Of ADHD Patch (NAPSA)—According to data presented at a recent medical meeting, Daytrana™ (methylphenidate transdermal system)—the first and only patch for Attention Deficit Hyperactivity Disorder (ADHD)—demonstrated statistically significant reductions in ADHD symptoms and was generally well tolerated in patients. In fact, in the study, children aged 6 to 12 years receiving Daytrana ver- sus placebo demonstrated significant improvement in math skills. This information comes after the recent U.S. Food and Drug Administration approval of Daytrana as a well-tolerated and effective, once- daily, ADHD medication for children aged 6 to 12 years. “Children with ADHD andtheir caregivers must manage symptom control throughout the day in a variety of settings, such as the classroom, after-school activities, or home,” explains clinical trials principal investigator Sharon Wigal, Ph.D., associate clinical pro- fessor of pediatrics at the University of California Irvine Child Development Center. “These studies document that a methylphenidate patch is an effective, once-daily ADHD treatment that can result in the improvement of multiple measures of behavior and math test performance.” Daytrana combines methylphenidate with a novel delivery system designed for consistent, smooth medication release throughout the day. Because Daytrana is a patch, physicians and parents can manage the duration of its effect and potential late-day side effects by having the child wear the patch for a shorter time period than the recommended nine hours on a given day. Daytranais designed to stay on during a child’s normal daily activities, like swimming or bathing. Daytrana is now available in retail pharmacies throughoutthe country. ADHDaffects approximately 8 percent of all school-age children or about 4.4 million U.S. children aged 4 to 17 years. Children who struggle with ADHD often have difficulty focusing and staying still, are easily distracted and are frequently unable to control their impulsive behavior. For some of these children, these symptoms can occur so much that they may cause significant impairments in social and schoolsettings. Medication can be an effective part of a treatment plan to manage your child’s ADHD symptoms. To learn more about Daytrana, please visit www.Daytrana.com. For more information on ADHD, visit www.ADHDSupport.com. we ee eee OSE ee ee ee eee Important Safety Information: Daytrana is a Schedule IT controlled substance. Tell your doctor about any heart conditions, including structural abnormalities, your child or a family member may have. Inform your doctor immediately if the child develops symptoms that suggest heart problems, such as chest pain or fainting. Daytrana should not be used if the child has: significant anxiety, tension, or agitation; allergies to methylphenidate or other ingredients of Daytrana; glaucoma; discontinued in the last 14 days or is taking a monoamine oxidase inhibitor (MAOD); tics, or family history or diagnosis of Tourette’s syndrome. Tell your doctor before using Daytrana if the child: is being treated for or has symptoms of depression (e.g. sadness, worthlessness, or hopelessness) or bipolar disorder; has family history of tics; has abnormal thoughts or visions, hears abnormal sounds, or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell your doctor immediately if the child develops any of these conditions /symptoms while using Daytrana. Daytrana was generally well tolerated in clinical studies. The most commonside effects reported with Daytrana were decreased appetite, sleeplessness, sadness /crying, twitching, weight loss, nausea, vomiting, tics, and affect lability (mood swings). Aggression, new abnormal thoughts / behaviors, mania, and growth suppression have been associated with use of drugs of this type. Tell your doctor if the child has blurred vision while using Daytrana. Abuse of Daytrana can lead to dependence. Daytrana should be applied daily to clean, dry skin, which is free of any cuts or irritation. Skin irritation or allergic skin rash may occur.
